P455 Adherence to enteral nutrition therapy by adults with active Crohn’s disease is associated with conscientiousness personality trait
ECCO'20 Vienna
2020
P458 Association between adalimumab serum levels and level of remission in Crohn’s disease
ECCO'20 Vienna
2020
P459 The impact of latent cytomegalovirus infection on the disease behaviour in patients with ulcerative colitis
ECCO'20 Vienna
2020
P460 Evaluation of potential mechanisms underlying the safety observations of filgotinib in clinical studies in rheumatoid arthritis
ECCO'20 Vienna
2020
P461 Intolerance to 5-aminosalicylate is a risk of poor prognosis in ulcerative colitis patients
ECCO'20 Vienna
2020
P462 Efficacy of ustekinumab for the prevention of postoperative recurrence in crohn’s disease. Data from clinical practice from the eneida registry
ECCO'20 Vienna
2020
P463 Induction of endoscopic response: a network meta-analysis of induction studies comparing ontamalimab with other treatments for moderate-to-severe ulcerative colitis
ECCO'20 Vienna
2020
P464 Vedolizumab concentrations in colonic mucosal tissue of ulcerative colitis patients inversely correlate with the severity of inflammation
ECCO'20 Vienna
2020
P465 Therapeutic drug monitoring in Crohn’s disease patients, a comparison between homogeneous mobility shift assay and point of care method
ECCO'20 Vienna
2020
P466 Is it possible avoid colectomy with rescue dual therapy with vedolizumab plus tacrolimus in ulcerative colitis that losing response to anti-tumour necrosis factor?
ECCO'20 Vienna
2020
P467 Can induction and maintenance serum vedolizumab levels predict long-term clinical outcome in inflammatory bowel disease (IBD)?
ECCO'20 Vienna
2020
P468 Switching from adalimumab originator to ABP 501 biosimilar: a multicentre North Italian study
ECCO'20 Vienna
2020
P469 Stay in class or switch out of class after anti-TNF failure in inflammatory bowel disease (IBD). Real-world data from a large district general hospital
ECCO'20 Vienna
2020
P471 What is the appropriate cut-off value of CRP to predict endoscopic remission in ulcerative colitis patients with clinical remission?
ECCO'20 Vienna
2020
P472 Optimising the development of apps for the management of inflammatory bowel disease and participation in clinical trials
ECCO'20 Vienna
2020